<DOC>
	<DOCNO>NCT02333773</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy irreversible electroporation ( IRE ) unresectable Portal venous tumor embolus .</brief_summary>
	<brief_title>Irreversible Electroporation ( IRE ) For Unresectable Portal Venous Tumor Emboli</brief_title>
	<detailed_description>By enrol patient unresectable Portal venous tumor embolus adapt enrolled criterion , study document first time safety short long term efficacy percutaneous intraoperative IRE unresectable Portal venous tumor embolus .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<criteria>Liver cancer diagnose positive biopsy noninvasive criterion , Liver cancer Portal venous tumor embolus , Not suitable surgical resection transplantation , ChildPugh class A , B Eastern Cooperative Oncology Group ( ECOG ) score 01 , A prothrombin time ratio &gt; 50 % , Platelet count &gt; 80x10^9/L , Ability patient stop anticoagulant antiplatelet therapy seven day prior seven day post NanoKnife procedure , Able comprehend willing sign write informed consent form ( ICF ) , Have life expectancy least 3 month . Cardiac insufficiency , ongoing coronary artery disease arrhythmia , Any active implant device ( eg Pacemaker ) , Women pregnant woman childbearing potential use acceptable method contraception , Have receive treatment investigational agent/ procedure within 30 day prior treatment NanoKnifeâ„¢ LEDC System , Are opinion Investigator unable comply visit schedule protocol evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>irreversible electroporation</keyword>
	<keyword>Portal venous tumor embolus</keyword>
</DOC>